Cheng Han

2.3k total citations · 1 hit paper
21 papers, 1.6k citations indexed

About

Cheng Han is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Cheng Han has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Cheng Han's work include Cancer, Hypoxia, and Metabolism (7 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Cheng Han is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Cheng Han collaborates with scholars based in United Kingdom, Australia and New Zealand. Cheng Han's co-authors include Adrian L. Harris, Stephen B. Fox, Russell Leek, Kevin C. Gatter, Peter H. Watson, Stephen Chia, Jaromı́r Pastorek, Charles C. Wykoff, Peter J. Ratcliffe and Helen Turley and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Cheng Han

21 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma

2001 364 citations Stephen Chia, Charles C. Wykoff et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheng Han United Kingdom	19	959	722	459	240	182	21	1.6k
Yuichi Ishikawa Japan	23	1.4k 1.4×	597 0.8×	476 1.0×	168 0.7×	202 1.1×	113	2.5k
Charlotte Kopitz Germany	19	981 1.0×	787 1.1×	639 1.4×	141 0.6×	142 0.8×	40	1.7k
Mary J. Dorie United States	23	978 1.0×	846 1.2×	611 1.3×	255 1.1×	62 0.3×	34	1.9k
Bin Shi China	10	1.2k 1.2×	606 0.8×	852 1.9×	219 0.9×	140 0.8×	16	2.1k
W. Gillies McKenna United States	23	1.1k 1.1×	463 0.6×	599 1.3×	126 0.5×	123 0.7×	37	1.8k
Dana T. Aftab United States	20	803 0.8×	417 0.6×	882 1.9×	156 0.7×	182 1.0×	45	1.8k
Josef Brueggen Switzerland	10	1.8k 1.9×	381 0.5×	633 1.4×	161 0.7×	123 0.7×	14	2.4k
Mei Dong China	18	1.2k 1.3×	332 0.5×	539 1.2×	119 0.5×	99 0.5×	36	1.7k
Amen Sibtain United Kingdom	11	1.0k 1.1×	730 1.0×	333 0.7×	78 0.3×	143 0.8×	21	1.7k
Nathan G. Dolloff United States	19	877 0.9×	296 0.4×	515 1.1×	201 0.8×	100 0.5×	41	1.4k

Countries citing papers authored by Cheng Han

Since Specialization

Citations

This map shows the geographic impact of Cheng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Han more than expected).

Fields of papers citing papers by Cheng Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Han. The network helps show where Cheng Han may publish in the future.

Co-authorship network of co-authors of Cheng Han

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Han. A scholar is included among the top collaborators of Cheng Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Han. Cheng Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aleksic, Tamara, Nicki Gray, Xiaoning Wu, et al.. (2018). Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage. Cancer Research. 78(13). 3497–3509. 50 indexed citations

Aleksic, Tamara, Clare Verrill, Richard J. Bryant, et al.. (2017). IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer. British Journal of Cancer. 117(11). 1600–1606. 38 indexed citations

Han, Cheng, et al.. (2015). Long‐term functional outcomes in surgically treated patients with oropharyngeal cancer. The Laryngoscope. 125(7). 1637–1643. 13 indexed citations

Payne, Miranda, Paul Lorigan, David Farrugia, et al.. (2013). Phase II Pilot Study of Intravenous High-Dose Interferon With or Without Maintenance Treatment in Melanoma at High Risk of Recurrence. Journal of Clinical Oncology. 32(3). 185–190. 24 indexed citations

Li, Ying, et al.. (2012). Ten SNPs of PAX6,Lumican, andMYOCgenes are not associated with high myopia in Han Chinese. Ophthalmic Genetics. 33(3). 171–178. 17 indexed citations

Payne, Miranda, Bethan Lang, Angela Vincent, et al.. (2010). Prospective Study into the Incidence of Lambert Eaton Myasthenic Syndrome in Small Cell Lung Cancer. Journal of Thoracic Oncology. 5(1). 34–38. 41 indexed citations

Ord, Jonathan, Sachin Agrawal, Thomas Paulraj Thamboo, et al.. (2007). An Investigation Into the Prognostic Significance of Necrosis and Hypoxia in High Grade and Invasive Bladder Cancer. The Journal of Urology. 178(2). 677–682. 49 indexed citations

Banham, Alison H., J. Boddy, Rosalind Launchbury, et al.. (2007). Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the Androgen receptor in prostate cancer but is not directly regulated by Androgens or hypoxia. The Prostate. 67(10). 1091–1098. 38 indexed citations

Tan, Ern Yu, Leticia Campo, Cheng Han, et al.. (2007). Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer. Breast Cancer Research. 9(6). R89–R89. 40 indexed citations

10.

Bates, Gaynor J., Stephen B. Fox, Cheng Han, et al.. (2007). Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptorβ in primary invasive breast carcinomas. Breast Cancer Research and Treatment. 111(3). 453–459. 44 indexed citations

11.

Tan, Ern Yu, Leticia Campo, Cheng Han, et al.. (2007). BNIP3 as a Progression Marker in Primary Human Breast Cancer; Opposing Functions inIn situVersus Invasive Cancer. Clinical Cancer Research. 13(2). 467–474. 77 indexed citations

12.

Winter, Stuart C., Ketan Shah, Cheng Han, et al.. (2006). The relation between hypoxia‐inducible factor (HIF)‐1α and HIF‐2α expression with anemia and outcome in surgically treated head and neck cancer. Cancer. 107(4). 757–766. 79 indexed citations

13.

Campo, Leticia, Helen Turley, Cheng Han, et al.. (2005). Angiogenin is up‐regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival. The Journal of Pathology. 205(5). 585–591. 41 indexed citations

14.

Madhusudan, Srinivasan, S. Muthuramalingam, Jeremy Braybrooke, et al.. (2005). Study of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian Cancer. Journal of Clinical Oncology. 23(25). 5950–5959. 126 indexed citations

15.

Fox, Stephen B., Philip J. Brown, Cheng Han, et al.. (2004). Expression of the Forkhead Transcription Factor FOXP1 Is Associated with Estrogen Receptor α and Improved Survival in Primary Human Breast Carcinomas. Clinical Cancer Research. 10(10). 3521–3527. 88 indexed citations

16.

Sowter, Heidi, Mary Ferguson, Peter H. Watson, et al.. (2003). Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade. The Journal of Pathology. 201(4). 573–580. 112 indexed citations

17.

Currie, Margaret J., Sarah Gunningham, Kevin Turner, et al.. (2002). Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel‐Lindau gene and hypoxia. The Journal of Pathology. 198(4). 502–510. 70 indexed citations

18.

Riisbro, Rikke, Ib Jarle Christensen, Timo Piironen, et al.. (2002). Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.. PubMed. 8(5). 1132–41. 100 indexed citations

19.

Gunningham, Sarah, Margaret J. Currie, Cheng Han, et al.. (2001). VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis. The Journal of Pathology. 193(3). 325–332. 53 indexed citations

20.

Chia, Stephen, Charles C. Wykoff, Peter H. Watson, et al.. (2001). Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma. Journal of Clinical Oncology. 19(16). 3660–3668. 364 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact